These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27500861)

  • 21. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of a patient with a circadian sleep-wake disorder using a combination of melatonin and metoprolol.
    Gehrman PR; Anafi RC
    J Clin Sleep Med; 2021 Oct; 17(10):2121-2124. PubMed ID: 34032203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the melatonin system in the control of sleep: therapeutic implications.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Cardinali DP
    CNS Drugs; 2007; 21(12):995-1018. PubMed ID: 18020480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tasimelteon (Hetlioz) for non-24-hour sleep-wake disorder.
    Med Lett Drugs Ther; 2014 Apr; 56(1441):34-5. PubMed ID: 24759294
    [No Abstract]   [Full Text] [Related]  

  • 25. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical neurophysiology of circadian rhythm sleep-wake disorders.
    Saeed Y; Zee PC; Abbott SM
    Handb Clin Neurol; 2019; 161():369-380. PubMed ID: 31307614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches.
    Hardeland R
    Curr Pharm Des; 2016; 22(8):1086-101. PubMed ID: 25248806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
    Burgess HJ; Emens JS
    Sleep Med Clin; 2022 Sep; 17(3):421-431. PubMed ID: 36150804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment.
    Wang YQ; Jiang YJ; Zou MS; Liu J; Zhao HQ; Wang YH
    Behav Brain Res; 2022 Feb; 420():113724. PubMed ID: 34929236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin receptor agonists: new options for insomnia and depression treatment.
    Spadoni G; Bedini A; Rivara S; Mor M
    CNS Neurosci Ther; 2011 Dec; 17(6):733-41. PubMed ID: 21554566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Depression-Related Circadian Rhythm Sleep-Wake Disorder (CRSWD) With Melatonin Receptor Agonist Ramelteon: A Case Report.
    Matsumoto S; Ohama R; Hoei T; Tojo R; Nakamura T
    Cureus; 2024 Aug; 16(8):e68311. PubMed ID: 39350880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin and its agonists: an update.
    Arendt J; Rajaratnam SM
    Br J Psychiatry; 2008 Oct; 193(4):267-9. PubMed ID: 18827285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
    Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Out of synch with society: an update on delayed sleep phase disorder.
    Nesbitt AD; Dijk DJ
    Curr Opin Pulm Med; 2014 Nov; 20(6):581-7. PubMed ID: 25160887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
    Burgess HJ; Emens JS
    Sleep Med Clin; 2018 Jun; 13(2):231-241. PubMed ID: 29759273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between Melatonin Receptor Agonists and Parkinson's Disease.
    Noguchi Y; Masuda R; Aizawa H; Yoshimura T
    J Pineal Res; 2024 Aug; 76(5):e13002. PubMed ID: 39119925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of depression: role of sleep and the melatonergic system.
    Srinivasan V; Pandi-Perumal SR; Trakht I; Spence DW; Hardeland R; Poeggeler B; Cardinali DP
    Psychiatry Res; 2009 Feb; 165(3):201-14. PubMed ID: 19181389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
    Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
    Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
    Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.